Clinical Trial Update: A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of Telisotuzumab Adizutecan in combination with standard colorectal cancer regimens (oxaliplatin, fluo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Panitumumab (panitumumab)
• Telisotuzumab Adizutecan (Telisotuzumab Adizutecan)

Snippet

Sponsor: AbbVie | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING